Mangrove Partners’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-450,000
Closed -$4.5M – 352
2022
Q4
$4.5M Hold
450,000
– – 0.25% 143
2022
Q3
$4.38M Buy
450,000
+376,644
+513% +$3.66M 0.25% 158
2022
Q2
$711K Buy
+73,356
New +$714K 0.03% 411

Other funds holding DALS

Mangrove Partners's DALS Position: Q1 2023 in Review

Mangrove Partners sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2023, closing a stake of 450,000 shares — an estimated $4.5M sold.

Mangrove Partners first reported a position in DALS in Q2 2022 and held it in 3 quarters. The position peaked at $4.5M in Q4 2022. 50 funds tracked by Wall St. Rank hold DALS as of Q1 2023.

  • Mangrove Partners reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 450,000 DA32 Life Science Tech Acquisition Corp shares in Q1 2023, an estimated $4.5M.
  • Mangrove Partners first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2022 and held it in 3 quarters.
  • Mangrove Partners's DA32 Life Science Tech Acquisition Corp position peaked at $4.5M in Q4 2022.
  • 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.